"non small cell lung" trang 13 - tải miễn phí từ tailieuXANH
Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis

Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis
11    82    0
Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
9    49    0
Identification of monotonically differentially expressed genes for non-small cell lung cancer

Identification of monotonically differentially expressed genes for non-small cell lung cancer
9    61    0
Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory

Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory
14    63    0
A retrospective study of alectinib versus ceritinib in patients with advanced non– small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

A retrospective study of alectinib versus ceritinib in patients with advanced non– small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed
8    134    1
A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: Rationale and study protocol design for the LOGIK1702 study

A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: Rationale and study protocol design for the LOGIK1702 study
6    46    1
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
11    31    1
LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p

LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p
13    58    1
A novel circular RNA hsa_circRNA_103809/ miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)

A novel circular RNA hsa_circRNA_103809/ miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)
11    49    1
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
16    50    1
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study
8    77    1
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
7    28    1
A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers
11    50    1
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027

A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027
10    52    1
Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelialmesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2

Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelialmesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2
10    48    1
A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
11    51    1
Spontaneous regression of ALK fusion protein-positive non-small cell lung carcinoma: A case report and review of the literature

Spontaneous regression of ALK fusion protein-positive non-small cell lung carcinoma: A case report and review of the literature
9    53    1
Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer

Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer
9    64    1
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: A retrospective analysis from the I-O Optimise initiative

Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: A retrospective analysis from the I-O Optimise initiative
13    37    1
Spontaneous remission of advanced progressive poorly differentiated non-small cell lung cancer: A case report and review of literature

Spontaneous remission of advanced progressive poorly differentiated non-small cell lung cancer: A case report and review of literature
7    54    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.